65,437 trials
Prostate Cancer
Primary: Changes in the Blood Chemistry (Fasting Triglycerides) After 8 Weeks of Following a Mediterranean Diet — 21 percentage of change
Myocardial Infarction · Comorbidity
Primary: Primary Outcome Was the Performance of Each Provider on Each of Seven Clinical Indicators — 2.8; 2.1; 11.5; 9.5 percentage of provider's patients
Allergic Rhinitis
Primary: Cmax (the Maximum Observed Plasma Concentration) — 1630.223; 1729.393; 1617.810 ng/mL
Dyspepsia
Primary: Visual Analogue Scale Score — 39.6; 42.3; 27.6; 28.3 Visual Analogue Scale
Back Pain Lower Back Chronic
Primary: Change From Baseline to Week 14 in Brief Pain Inventory (BPI) 24-Hour Average Pain Severity Item — -2.43; -1.96 units on a scale — p=0.0026
Chronic Low Back Pain · Mechanical Low Back Pain
Primary: Flexion-relaxation Ratio — 0.68 Ratio
Migraine
Primary: Visual Analogue Scale Change — 55; 30 units on a scale
Diabetes Mellitus, Type 2
Primary: HbA1c (Glycosylated Haemoglobin) Change From Baseline at Week 16 — -0.83; -0.72; -0.66; -0.64 percentage of HbA1c — p=<0.0001
Non-Hodgkin's Lymphoma
Primary: Percentage of Participants Achieving CR or PR at the End of Therapy — 75.0; 92.4 percentage of participants — p=0.0009
Tobacco Use Disorder
Primary: Cigarette Reduction — 10; 11 participants
Major Depressive Disorder
Primary: Response of Participants, Defined by Change in the 21-item Hamilton Depression Rating Scale (HDRS) From Baseline to Week8 — 5; 9; 2; 4 participants — p=.918
Renal Failure
Primary: Evaluation of Steady State Tacrolimus Trough Levels (C24). — 7.00 ng/mL
Healthy Volunteers
Primary: Insulin Sensitivity as Measured by Hyperinsulinemic Euglycemic Clamp at a Single Time Point (6 Hrs) After Intralipid or Glycerol Infusion — 8; 12; 6; 11 M value — p=<0.05
Sedation, Conscious
Primary: Sedation Scale Score — 0; 0; 0; 1 participants — p=0.99
ACTINIC KERATOSES
Primary: Change in Lesion Counts in 25 cm2 Target Area Relative to Baseline. — -72; -37.5 lesions